Deferasirox-induced urticarial vasculitis in a patient with myelodysplastic syndrome*
Sign Up to like & getrecommendations! Published in 2017 at "Anais Brasileiros de Dermatologia"
DOI: 10.1590/abd1806-4841.20176688
Abstract: Deferasirox is an iron chelator agent used in the treatment of diseases with iron overload, such as thalassemia and myelodysplastic syndrome. Although the majority of adverse reactions of deferasirox involve gastrointestinal symptoms and increase in… read more here.
Keywords: deferasirox; urticarial vasculitis; myelodysplastic syndrome; deferasirox induced ... See more keywords